TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28558252

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise at 40%-50% oxygen uptake reserve (LI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-intensity exercise at 70%-80% oxygen uptake reserve (HI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-intensity exercise plus EPOC re-feeding (HI+EERM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonexercise control
Number of subjects: 0
Study: 25928161

Group type: EXPERIMENTAL
Intervention: Physical activity module
Number of subjects: 1828

Group type: EXPERIMENTAL
Intervention: Smoking module
Number of subjects: 1828

Group type: EXPERIMENTAL
Intervention: Fruit module
Number of subjects: 1828

Group type: EXPERIMENTAL
Intervention: Vegetable module
Number of subjects: 1828

Group type: EXPERIMENTAL
Intervention: Alcohol module
Number of subjects: 1828

Group type: EXPERIMENTAL
Intervention: Tobacco use module
Number of subjects: 1828
Study: 23702006

Group type: EXPERIMENTAL
Intervention: Transfusion with pre-storage leuko-depleted RBC suspended in saline-adenine-glucose and mannitol (SAGM) at haemoglobin level (Hb) of 7 g/dl
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Transfusion with pre-storage leuko-depleted RBC suspended in saline-adenine-glucose and mannitol (SAGM) at haemoglobin level (Hb) of 9 g/dl
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Transfusion with pre-storage leuko-depleted RBC suspended in saline-adenine-glucose and mannitol (SAGM)
Number of subjects: 1000
Study: 21837955

Group type: COMPARATOR
Intervention: Plasmakinetic transurethral resection of the prostate (PKRP)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Transurethral detaching resection (TUDRP)
Number of subjects: 81
Study: 19627013

Group type: EXPERIMENTAL
Intervention: 0.3% ropivacaine (60 mL: lumbar-plexus 36 mL, sciatic nerve 24 mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.4% ropivacaine (45 mL: lumbar-plexus 27 mL, sciatic nerve 18 mL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.3% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.4% ropivacaine
Number of subjects: 60
Study: 17556348

Group type: COMPARATOR
Intervention: Single-vessel disease
Number of subjects: 2082

Group type: COMPARATOR
Intervention: Double-vessel disease
Number of subjects: 2082

Group type: COMPARATOR
Intervention: Triple-vessel disease
Number of subjects: 2082
Study: 15167303

Group type: EXPERIMENTAL
Intervention: Mid-dose (40 mg isoflavones + 500 mg calcium)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: High-dose (80 mg isoflavones + 500 mg calcium)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo (0 mg isoflavones + 500 mg calcium)
Number of subjects: 203
Study: 11874640

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group therapy (CBT)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Peer support/counseling group therapy (PSC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Routine treatment with no formal psychosocial intervention (Control)
Number of subjects: 46
Study: 9805118

Group type: EXPERIMENTAL
Intervention: Blood samples obtained from peripheral venous catheters
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 18-gauge catheters
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 20-gauge catheters
Number of subjects: 53

Group type: COMPARATOR
Intervention: Venipuncture (control group)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Peripheral catheter samples
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Acceptable interval for potassium measurements
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Acceptable interval for hemoglobin measurements
Number of subjects: 53
Study: 8690170

Group type: EXPERIMENTAL
Intervention: Hypoglycaemia (2.9 mmol/l) for 2 hours during hypo week
Number of subjects: 8

Group type: COMPARATOR
Intervention: Euglycaemia (5 mmol/l) for 2 hours during control week
Number of subjects: 8
Study: 2543203

Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber diet (25% of calories from fat, P:S of 1.0, 200 mg cholesterol/d, 40 g dietary fiber/d)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Typical Western diet (40% of total calories from fat, 400 mg cholesterol/d, 12 g dietary fiber/d, P:S of 0.5)
Number of subjects: 17
Study: 1106810

Group type: EXPERIMENTAL
Intervention: Ibuterol hydrochloride 2 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ibuterol hydrochloride 4 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Terbutaline 5 mg
Number of subjects: 12
Study: 31996581

Group type: EXPERIMENTAL
Intervention: Minimal open hemorrhoidectomy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Transanal hemorrhoidal dearterialization
Number of subjects: 98
Study: 30350096

Group type: EXPERIMENTAL
Intervention: Transumbilical incision
Number of subjects: 102
Study: 25533591

Group type: EXPERIMENTAL
Intervention: Therapeutic continuous positive airway pressure (CPAP) for 8 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham continuous positive airway pressure for 8 weeks
Number of subjects: 29
Study: 23220074

Group type: EXPERIMENTAL
Intervention: DHA 250 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: DHA 500 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 21304095

Group type: EXPERIMENTAL
Intervention: losartan
Number of subjects: 8696

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 8696

Group type: EXPERIMENTAL
Intervention: black race
Number of subjects: 8696
Study: 19255065

Group type: EXPERIMENTAL
Intervention: PURPLE materials
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Control materials
Number of subjects: 1279
Study: 16762668

Group type: EXPERIMENTAL
Intervention: Rasch mathematical model (RMM) applied to examination 1 with up to 20% of student responses randomly missing.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rasch mathematical model (RMM) applied to examination 1 with up to 40% of items being dropped.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rasch mathematical model (RMM) applied to combined examinations 1 and 2.
Number of subjects: 100
Study: 15016284

Group type: EXPERIMENTAL
Intervention: Odor imagery
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Visual imagery
Number of subjects: 72

Group type: COMPARATOR
Intervention: No-imagery control
Number of subjects: 72
Study: 11728613

Group type: EXPERIMENTAL
Intervention: Amineptine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 9598014

Group type: EXPERIMENTAL
Intervention: 5% glycolic acid cream
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 75
Study: 7930717

Group type: EXPERIMENTAL
Intervention: HLA-DR+ CD38+ CD8+ cell population
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stable CD4+ cell levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term survivors (seropositive for 9 years, > 800 CD4+ cells/mm3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective elevation of HLA-DR+ CD38- CD8+ cells
Number of subjects: 0
Study: 3078907

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 29099396

Group type: EXPERIMENTAL
Intervention: Laparoscopic distal pancreatectomy (LDP)
Number of subjects: 3701

Group type: COMPARATOR
Intervention: Open distal pancreatectomy (ODP)
Number of subjects: 3701
Study: 26443707

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia-hyperoxia training combined with light exercise (O2 at 10% and O2 at 30%, 6-8 cycles, total time 45 min-1 h, three times a week for 4 weeks)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia-hyperoxia training combined with light exercise
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (19 healthy athletes following usual training schedule)
Number of subjects: 15
Study: 24846511

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 61

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 61
Study: 23772156

Group type: EXPERIMENTAL
Intervention: Lactulose breath test positive (LBT (+)) IBS patients
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Methane producers
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: LBT (+) IBS patients
Number of subjects: 68

Group type: COMPARATOR
Intervention: LBT (−) IBS patients
Number of subjects: 68

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 68
Study: 22256334

Group type: EXPERIMENTAL
Intervention: 62% ethyl alcohol in emollient gel applied by male partners each morning and before and after sexual intercourse
Number of subjects: 223

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 223
Study: 19501210

Group type: EXPERIMENTAL
Intervention: DMPA-SC
Number of subjects: 266

Group type: COMPARATOR
Intervention: DMPA-IM
Number of subjects: 266
Study: 16584059

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 0.4 mg FA
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 1 mg FA
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 5 mg FA
Number of subjects: 61
Study: 14667178

Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no orlistat)
Number of subjects: 14
Study: 10801249

Group type: EXPERIMENTAL
Intervention: Enteric-coated methylnaltrexone (6.4 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enteric-coated methylnaltrexone (3.2 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Morphine (control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enteric-coated methylnaltrexone (3.2 mg/kg) after morphine
Number of subjects: 12
Study: 8618436

Group type: EXPERIMENTAL
Intervention: IFN alone in early CP (Group 1: 160 patients)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: IFN alone in late CP (Group 2: 31 patients)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: IFN before and after autologous stem cell transplantation (ASCT) (Group 3: 23 patients)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: IFN after ASCT (Group 4: 24 patients)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Responders to IFN
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Non-responders to IFN
Number of subjects: 238
Study: 1473672

Group type: EXPERIMENTAL
Intervention: Air contrast barium enema performed the same day as incomplete colonoscopy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Air contrast barium enema performed on a different day from incomplete colonoscopy
Number of subjects: 38
Study: 6392159

Group type: EXPERIMENTAL
Intervention: Hexabrix
Number of subjects: 51

Group type: COMPARATOR
Intervention: Renografin 60
Number of subjects: 51
Study: 31631761

Group type: EXPERIMENTAL
Intervention: Telehealth peer-support programme delivered by videoconferencing for 6 weeks
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Telehealth peer-support programme delivered by videoconferencing
Number of subjects: 69
Study: 29221645

Group type: EXPERIMENTAL
Intervention: Weight management programme (intervention)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Best-practice care by guidelines (control)
Number of subjects: 306
Study: 27619832

Group type: EXPERIMENTAL
Intervention: Pneumatic dilation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Laparoscopic Heller myotomy with partial fundoplication
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 24793176

Group type: EXPERIMENTAL
Intervention: Monthly intervention group (GIM): instructions on fall prevention and healthy exercises with monthly refresher sessions.
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Quarterly intervention group (GIT): same beginning intervention with refresher sessions every three months.
Number of subjects: 249

Group type: COMPARATOR
Intervention: Control group (GC): same beginning intervention but no refresher sessions.
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 249
Study: 22537767

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (1mg/day)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oral estradiol (2 mg/day)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oral estradiol (2 mg/day) + MPA (5mg/day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Estradiol-only therapy
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All hormone regimens
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Estradiol-only regimen
Number of subjects: 150
Study: 20666584

Group type: EXPERIMENTAL
Intervention: tgAAC09 (3 x 10(10) DRP)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: tgAAC09 (3 x 10(11) DRP)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: tgAAC09 (3 x 10(12) DRP)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: tgAAC09 (2 doses)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: tgAAC09 (boosting at 6 months)
Number of subjects: 91
Study: 17346816

Group type: EXPERIMENTAL
Intervention: Nicorandil (4 mg intravenous bolus followed by 6 mg/h continuous infusion for 24 h)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no nicorandil)
Number of subjects: 49
Study: 11298145

Group type: EXPERIMENTAL
Intervention: Ceftazidime with acetazolamide (subgroup A)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Ceftazidime without acetazolamide (subgroup B)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Cefotaxime with acetazolamide (subgroup A)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Cefotaxime without acetazolamide (subgroup B)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Aztreonam with acetazolamide (subgroup A)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Aztreonam without acetazolamide (subgroup B)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Ceftriaxone with acetazolamide (subgroup A)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Ceftriaxone without acetazolamide (subgroup B)
Number of subjects: 188
Study: 9213790

Group type: EXPERIMENTAL
Intervention: Early introduction of slow‐acting antirheumatic drugs (SAARDs)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Delayed introduction of slow‐acting antirheumatic drugs (SAARDs)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Both groups (early SAARD and delayed SAARD)
Number of subjects: 304
Study: 7963710

Group type: EXPERIMENTAL
Intervention: Antiviral therapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Interleukin-2 treatment
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: bDNA assay
Number of subjects: 102
Study: 3315588

Group type: EXPERIMENTAL
Intervention: Anisoylated plasminogen streptokinase activator complex (APSAC) administered as an intravenous bolus of 30U
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intracoronary streptokinase (250,000U)
Number of subjects: 16
Study: 31261549

Group type: EXPERIMENTAL
Intervention: Individualized graded lumbar stabilization exercise (IGLSE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Walking exercise (WE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Stabilization exercise (SE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Stabilization with walking exercise (SWE)
Number of subjects: 48
Study: 28330385

Group type: EXPERIMENTAL
Intervention: Community health workers intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Attentional control
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 25868758

Group type: EXPERIMENTAL
Intervention: Femtosecond laser flap creation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Mechanical microkeratome flap creation
Number of subjects: 21
Study: 23584130

Group type: EXPERIMENTAL
Intervention: Serum adalimumab concentration at week 4 of CLASSIC I
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Serum adalimumab concentration at weeks 4, 24, and 56 of CLASSIC II
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Baseline Crohn's Disease Activity Index, baseline C-reactive protein, and adalimumab concentrations
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic curves
Number of subjects: 275
Study: 21204686

Group type: EXPERIMENTAL
Intervention: Brief Direct Treatment Intervention (BDTI)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Telephone Quitline (TQ)
Number of subjects: 192
Study: 18050385

Group type: EXPERIMENTAL
Intervention: Rituximab 500 mg
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Rituximab 1000 mg
Number of subjects: 367

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study: 16924028

Group type: EXPERIMENTAL
Intervention: Patients with early HD
Number of subjects: 13

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 13
Study: 12939099

Group type: EXPERIMENTAL
Intervention: Medical care with physical therapy
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Medical care without physical therapy
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Chiropractic care with physical modalities
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Chiropractic care without physical modalities
Number of subjects: 681
Study: 10716674

Group type: EXPERIMENTAL
Intervention: Sumatriptan, 6 mg subcutaneously
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9374124

Group type: EXPERIMENTAL
Intervention: 3 g/d fish oil
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 6 g/d fish oil
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 9 g/d fish oil
Number of subjects: 58

Group type: COMPARATOR
Intervention: 0 g/d fish oil (control)
Number of subjects: 58
Study: 1347210

Group type: EXPERIMENTAL
Intervention: Breathing Retraining and Cognitive Restructuring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Graded Self-Exposure in vivo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of Breathing Retraining and Cognitive Restructuring with Self-Exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Further treatment during follow-up period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Demographic variables, pre- and posttest scores, medication use
Number of subjects: 0
Study: 30165804

Group type: EXPERIMENTAL
Intervention: Single needle arthrocentesis with distention of the upper compartment of the TMJ (A1)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional arthrocentesis with 2 needles (A2)
Number of subjects: 26
Study: 29185901

Group type: EXPERIMENTAL
Intervention: Central reader PET/CT interpretation
Number of subjects: 356

Group type: COMPARATOR
Intervention: Local institutional review
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Central reader AUC
Number of subjects: 356

Group type: COMPARATOR
Intervention: Local institutional AUC
Number of subjects: 356
Study: 27046570

Group type: EXPERIMENTAL
Intervention: Cryoslide (VR game)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 25193003

Group type: EXPERIMENTAL
Intervention: Treatment (TX)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlist (WLC)
Number of subjects: 42
Study: 23732372

Group type: EXPERIMENTAL
Intervention: Tuberil® (weight-loss supplement derived from potato)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 0
Study: 20163990

Group type: EXPERIMENTAL
Intervention: Interferon beta and high-dose daclizumab (2 mg/kg every 2 weeks)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Interferon beta and low-dose daclizumab (1 mg/kg every 4 weeks)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Interferon beta and placebo
Number of subjects: 230
Study: 18335727

Group type: EXPERIMENTAL
Intervention: Microfilled resin composite (Filtek A110) with a one‐bottle bonding system (Single Bond)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Polyacid‐modified resin composite (compomer) (Dyract AP) with a filled one‐bottle bonding system (Prime & Bond NT) using 36% phosphoric acid pretreatment
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Polyacid‐modified resin composite (compomer) (Dyract AP) with a filled one‐bottle bonding system (Prime & Bond NT) using a non‐rinse conditioner (NRC) and a self‐priming pretreatment
Number of subjects: 96

Group type: COMPARATOR
Intervention: All groups (Microfilled resin composite and both compomers)
Number of subjects: 96
Study: 16272001

Group type: EXPERIMENTAL
Intervention: Group S (n = 12) - responded to reversible sentences in a computerized game
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Group M (n = 12) - same stimuli acoustically modified
Number of subjects: 33

Group type: COMPARATOR
Intervention: Group U (n = 9) - untrained control group
Number of subjects: 33
Study: 14614782

Group type: EXPERIMENTAL
Intervention: Transverse abdominal incision
Number of subjects: 172

Group type: COMPARATOR
Intervention: Vertical abdominal incision
Number of subjects: 172
Study: 11938858

Group type: EXPERIMENTAL
Intervention: Salvia miltiorrhiza compound injection (SMCI) 200 mg/kg intravenously before operation and at rewarming
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 20
Study: 9358725

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 26
Study: 1302811

Group type: EXPERIMENTAL
Intervention: Isoconazole nitrate (1% cream, Travogen)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clotrimazole (1% cream, Canestan)
Number of subjects: 40
Study: 3891821

Group type: EXPERIMENTAL
Intervention: Diltiazem (240 mg/day and 120 mg/day)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Diltiazem (high dose 240 mg/day)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 126
Study: 30741790

Group type: EXPERIMENTAL
Intervention: PLLA injections
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline injections (control group)
Number of subjects: 40
Study: 30087216

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (6 g/d for 8 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Medium chain triglycerides oil (6 g/d for 8 weeks)
Number of subjects: 34